Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the manufacturing facility of Medispray Laboratories Private Limited, a ...

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 we hereby notify that the Operations and Administrative Committee of the ...

After a 13 per cent decline from its peak of March 2025 over the past three weeks, Cipla has fallen into oversold territory. However, recent trading activity suggests a potential shift in trend.

The Western Cape High Court has interdicted Cipla Medpro from infringing its competitors' trademark. The Western Cape High Court has interdicted Cipla Medpro (Pty) Ltd from passing off its ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and Drug ...

Technical charts hint that pharma shares such as Cipla, Lupin, Sun Pharma, Zydus Lifesciences and Gland Pharma could slide up to 23% as Trump tariff threat on pharma import looms.

Global brokerage firm Jefferies, in it latest note on India's Information Technology (IT) sector, warned that growing uncertainty and a potentially worsening business outlook, especially following the ...

Cipla is currently valued at Rs 1431.0, with a gain of 3.35% today, while its one-month returns stand at a decrease of 1.88%. The Indian oral rehydration solution market, valued at Rs 1000 crore, is ...

Lupin, Gland Pharma and Zydus Lifesciences saw significant losses, with shares dropping between 3% and 5%. Sun Pharma and Cipla also experienced declines. Give your business an edge with our leading ...

Gurugram's CyberHub became the unexpected host of a giant 10-foot peanut, leaving passersby amused and curious. Chayan Garg, whose LinkedIn bio describes him as a branding consultant, stumbled ...

UAE outlines new tax rule for foreign investors and non-residents: All you need to know The new decision specifies the cases in which a non-resident juridical investor in a Qualifying Investment ...

This move is expected to affect directly or indirectly many Indian corporates, including IT giants TCS and Infosys, automobile firms like Tata Motors, pharmaceutical companies such as Sun Pharma and ...